Zhenfeng Duan Selected Research

Zhenfeng Duan Research Topics

Disease

116	Neoplasms (Cancer) 05/2022 - 10/2000
59	Osteosarcoma (Osteogenic Sarcoma) 05/2022 - 01/2009
35	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2003
27	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 08/2009
20	Chordoma 12/2020 - 06/2009
19	Neoplasm Metastasis (Metastasis) 05/2022 - 07/2014
11	Breast Neoplasms (Breast Cancer) 02/2022 - 03/2005
9	Carcinogenesis 02/2022 - 05/2015
7	Chondrosarcoma 01/2021 - 09/2009
6	Liposarcoma 01/2022 - 01/2014
5	Synovial Sarcoma (Synovioma) 05/2022 - 01/2016
5	Carcinoma (Carcinomatosis) 01/2020 - 01/2003
4	Necrosis 01/2020 - 07/2014
3	Ewing Sarcoma (Sarcoma, Ewing) 04/2019 - 09/2009
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2016 - 11/2012
3	Hypoxia (Hypoxemia) 02/2011 - 01/2011
3	Adenocarcinoma 06/2010 - 05/2008
2	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 10/2019
2	Testicular Neoplasms (Testicular Cancer) 01/2020 - 07/2003
2	Intervertebral Disc Degeneration 10/2016 - 01/2016
2	Body Weight Changes 10/2015 - 05/2008
2	Retinoblastoma (Glioblastoma, Retinal) 01/2015 - 06/2012
2	Prostatic Neoplasms (Prostate Cancer) 11/2012 - 11/2008
2	Renal Cell Carcinoma (Grawitz Tumor) 11/2012 - 11/2008

Drug/Important Bio-Agent (IBA)

43	Pharmaceutical PreparationsIBA 01/2021 - 10/2000
39	Small Interfering RNA (siRNA)IBA 05/2022 - 07/2004
32	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 01/2003
30	Proteins (Proteins, Gene)FDA Link 12/2020 - 09/2004
27	Biomarkers (Surrogate Marker)IBA 05/2022 - 09/2009
22	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 07/2003
16	MicroRNAs (MicroRNA)IBA 02/2022 - 06/2010
15	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2022 - 01/2014
10	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2000
10	Phosphotransferases (Kinase)IBA 03/2018 - 04/2010
9	Biological ProductsIBA 01/2021 - 01/2012
8	Cisplatin (Platino)FDA LinkGeneric 12/2021 - 03/2009
8	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2018 - 05/2010
7	Messenger RNA (mRNA)IBA 01/2022 - 07/2014
6	Protein Kinases (Protein Kinase)IBA 01/2022 - 09/2014
6	EnzymesIBA 01/2021 - 05/2007
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 04/2011
6	palbociclibIBA 05/2018 - 01/2016
5	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 03/2018 - 12/2010
5	PolymersIBA 08/2017 - 07/2008
5	Interleukin-6 (Interleukin 6)IBA 01/2014 - 11/2007
5	CeramidesIBA 06/2010 - 05/2007
4	Histone Deacetylase InhibitorsIBA 09/2017 - 02/2011
4	LigandsIBA 05/2017 - 01/2014
4	(2- (4- methoxyphenyl)- 4- quinolinyl)(2- piperidinyl)methanolIBA 10/2015 - 10/2009
4	Dextrans (Dextran)FDA Link 01/2015 - 11/2009
4	CytokinesIBA 01/2014 - 09/2006
4	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 06/2011 - 08/2009
4	bardoxolone methylIBA 08/2010 - 03/2009
3	Methylnitronitrosoguanidine (MNNG)IBA 05/2022 - 01/2018
3	AntigensIBA 01/2020 - 07/2003
3	CyclinsIBA 01/2020 - 05/2015
3	Keratins (Keratin)IBA 01/2020 - 06/2010
3	Cyclin-Dependent Kinase 9IBA 01/2019 - 01/2019
3	SurvivinIBA 01/2019 - 11/2006
3	B7-H1 AntigenIBA 01/2019 - 05/2015
3	Cyclin-Dependent Kinase 4IBA 05/2018 - 01/2018
3	Hyaluronic Acid (Hyaluronan)IBA 01/2018 - 02/2015
3	Antineoplastic Agents (Antineoplastics)IBA 09/2017 - 03/2013
3	Untranslated RNA (Noncoding RNA)IBA 09/2017 - 12/2016
3	abexinostatIBA 04/2015 - 02/2011
3	LipidsIBA 01/2015 - 11/2009
3	Indicators and Reagents (Reagents)IBA 01/2013 - 06/2010
3	Brachyury protein (Brachyury)IBA 01/2013 - 01/2011
3	AcidsIBA 08/2010 - 11/2007
3	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2010 - 11/2006
3	PM 00104IBA 06/2010 - 05/2009
3	TrabectedinIBA 06/2010 - 05/2009
2	RNA Polymerase II (RNA Polymerase B)IBA 05/2022 - 01/2020
2	berzosertibIBA 01/2022 - 01/2020
2	OTS514IBA 12/2021 - 10/2020
2	VimentinIBA 01/2020 - 06/2010
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 06/2010
2	Tyrosine Kinase InhibitorsIBA 01/2019 - 08/2009
2	Therapeutic UsesIBA 01/2019 - 06/2017
2	Apoptosis Regulatory ProteinsIBA 01/2019 - 02/2016
2	Long Noncoding RNAIBA 01/2019 - 03/2017
2	Androgen Receptors (Androgen Receptor)IBA 08/2018 - 01/2017
2	Tyrosine (L-Tyrosine)FDA Link 03/2018 - 12/2010
2	Biocompatible Materials (Biomaterials)IBA 08/2017 - 06/2015
2	Coloring Agents (Dyes)IBA 01/2016 - 04/2014
2	Ethylene Glycol (Monoethylene Glycol)IBA 06/2015 - 03/2013
2	Carrier Proteins (Binding Protein)IBA 10/2014 - 06/2012
2	Nucleic AcidsIBA 08/2014 - 01/2014
2	PI103IBA 01/2014 - 06/2009
2	Caspase 3 (Caspase-3)IBA 04/2011 - 05/2010
2	lonidamineIBA 02/2011 - 01/2011

Therapy/Procedure

53	Therapeutics 02/2022 - 05/2003
48	Drug Therapy (Chemotherapy) 05/2022 - 07/2003
10	Radiotherapy 04/2019 - 02/2011
6	Neoadjuvant Therapy 12/2020 - 12/2010
4	Aftercare (After-Treatment) 02/2016 - 09/2009
2	Immunotherapy 01/2020 - 07/2003
2	Precision Medicine 12/2018 - 01/2011
2	Adjuvant Chemotherapy 06/2013 - 05/2010